Full-Time
Bupa
10,001+ employees
International healthcare provider serving millions
Compensation Overview
£47.5k - £52.5k/yr
Junior, Mid
London, UK + 1 more
More locations: Brighton, UK
Hybrid working options available; specific office locations are Angel Court, London and Victory House, Brighton.
- Proficient use of Figma and other design tools
- Good understanding of accessibility requirements
- Ability to work in an agile environment with multidisciplinary teams
- Proven track record of delivering UX/UI solutions that enhance business KPIs
- Comfortable and confident in managing stakeholder expectations
- Experience using a variety of user research methods
- Excellent communication skills, including facilitation
- Portfolio of mobile and web design projects
- Understand business requirements and translate them into designs and journeys for the User Interface
- Create UX artefacts such as sketches, wireframes, customer journey maps, user flows, and interactive prototypes (use of Figma is essential)
- Define the visual style and position relative to design guidelines
- Iterate designs based on feedback to produce production-ready products
- Manage the end-to-end design process from discovery to go live
- Ensure digital product journeys are on brand, compliant, accessible, and optimised for all screen sizes
- Create, update, and utilise in-house design systems
- Demonstrate understanding of market, technological, industry trends, accessibility, and user-centred design principles and user research methods
- Experience in a global environment is an advantage (agency and/or client side)
- An innovative and positive team player with a ‘can do’ attitude
- Self-starter with the ability to effectively prioritise own workload based on project demands
Bupa provides healthcare services aimed at improving the quality of life for its customers. The company operates internationally, serving over 38 million people across various countries. Bupa's services include health insurance, care homes, and health assessments, which are designed to support individuals in living longer and healthier lives. Unlike many other healthcare companies, Bupa does not have shareholders; instead, it reinvests its profits back into enhancing healthcare services for its customers. This commitment to customer welfare sets Bupa apart from its competitors. The company's goal is to create a healthier world by ensuring that its services are accessible and beneficial for both current and future customers.
Company Size
10,001+
Company Stage
Acquired
Total Funding
$217.8M
Headquarters
London, United Kingdom
Founded
1974
Simplify's Take
What believers are saying
- Bupa's GP subscription service aligns with the telemedicine trend, offering convenience.
- Whole genome sequencing pilot positions Bupa at the forefront of personalized healthcare.
- Acquisitions like London Medical expand Bupa's direct-to-consumer healthcare offerings.
What critics are saying
- Increased competition in genomic health could impact Bupa's market share.
- Ethical concerns over genome sequencing may lead to privacy scrutiny.
- Integration challenges with new acquisitions may cause operational inefficiencies.
What makes Bupa unique
- Bupa's 'My Genomic Health' pilot leads in personalized medicine and genomics.
- Acquisition of The Dermatology Partnership enhances Bupa's specialized health services.
- Bupa's mental health campaign with New Zealand athletes promotes wellness and reduces stigma.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Paid Vacation
Life Insurance
401(k) Retirement Plan
Performance Bonus
Gym Membership
Hybrid Work Options
Company News
Uniting past and present athletes from the internationally-renowned All Blacks, All Black Sevens, Black Ferns and Black Ferns Sevens, the campaign follows global research from Bupa revealing that 71% of young adults (18–44 year-olds) believe role models can inspire positive health change.Each player is captured not just as an athlete but as a person with a word they have personally chosen to represent their unique health and wellness story – from depression, anxiety and loss, to stroke, cancer and diabetes – displayed on the individual, revealing the human behind the jersey.Ruby Tui, current Black Fern #235, 2020 Olympic gold medallist, and 2021 World Cup winner, said: "There are a lot of eyes on you when you're a high-performance athlete, but the human story beyond the pitch can often be overlooked when it's just as important for us as individuals. I hope this campaign from Bupa sheds light on the importance of our individual health and wellness journeys and inspires more people to make their health a priority that they talk about openly and honestly."Among the stories featured, 2011 World Cup winner Aaron Cruden reflects on his battle with testicular cancer, while Maiakawanakaulani Roos, the youngest-ever captain of the Black Ferns, opens up about how personal loss during high school shaped her approach to teamwork and leadership. All stories can be found in more depth, alongside their bio below.To complement these personal narratives, Iain Saunders, Mental Skills Coach for the Black Ferns, shares five key lessons that can positively impact the mental and physical health of athletes and non-athletes alike:Work through it together: High performance isn't a solo act – and personal challenges needn't be either. The best teams thrive on connection, shared experience, and collective energy. Lean into your people and let them lean on you. Wellbeing is non-negotiable: High performance teams don't win championships by burning out
Dr Jose-Carlos Gutiérrez- Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public marketsHe brings a wealth of experience across biotechs and pharmaceutical companies, combined with deep expertise in science and tech for successful drug discovery, drug development programmes, and marketed drugsThe appointment strengthens the company's commercial capabilities, life sciences innovation, and R&D offering, to advance Genomics' mission of changing the future of healthcareOXFORD, England, Jan. 9, 2025 /PRNewswire/ -- Genomics , a healthcare company using large-scale genetic information to develop innovative precision healthcare tools and to bring new understanding to drug discovery, today announced the appointment of Dr Jose-Carlos Gutiérrez-Ramos to its Board. The appointment will support the company's rapid growth and strengthen its commercial offering globally, with a focus on scaling its life sciences business. The announcement coincides with significant Genomics presence at the J.P
Bupa Health Services has acquired The Dermatology Partnership (TDP) from August Equity to enhance its direct-to-consumer offerings. The financial details of the deal were not disclosed. This acquisition aims to reduce long waiting times for dermatology services in the UK, benefiting Bupa's UK Insurance customers.
Bupa has launched a two-year pilot program called "My Genomic Health," establishing itself as the first major private healthcare provider in the UK to offer whole genome sequencing to selected customers.
Bupa launches gene-mapping programme to tackle common disorders with tailored 'health plans'